Farcast Biosciences
Christopher Davitt, PhD, currently serves as the Director of Partnerships and Commercial Strategy at Farcast Biodynamics since March 2024. Previously, Christopher held various positions at BostonGene from January 2022 to March 2024, including Associate Director of Business Development and Alliance Management. Prior experience includes roles as Principal Scientist at DeepCure and Senior Scientist in Immunology at GreenLight Biosciences, as well as significant contributions to the field of immunology during tenures at Evelo Biosciences, Tulane University, and Trinity College Dublin. Academic credentials include a PhD in Oral Vaccination, Enteric Diseases and Mucosal Immunology from Trinity College Dublin, complemented by a Professional Diploma in International Business Studies. Christopher has demonstrated extensive expertise in immune assays, vaccine development, and strategic partnership cultivation throughout a diverse career in both research and business development.
This person is not in any teams
This person is not in any offices
Farcast Biosciences
2 followers
Farcast is a clinical diagnostic company whose mission it is to illuminate personal treatment truth of a cancer patient. The Farcast technology core is a human tumor micro-environment that enables oncologists and drug developers to test individual tumors to determine treatment response profiles. The company has its headquarters in Boston inMassachusetts, and operates a lab in Bangalore in India.